F13.25 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder

Name of the Condition

• Sedative, Hypnotic, or Anxiolytic Dependence with Sedative, Hypnotic or Anxiolytic-Induced Psychotic Disorder (ICD-10 Code: F13.25)

Summary

This condition involves a pattern of sedative, hypnotic, or anxiolytic use leading to dependence, accompanied by a substance-induced psychotic disorder. It is characterized by both physical or psychological reliance on these drugs and the presence of psychotic symptoms (e.g., delusions, hallucinations) directly resulting from their use.

Causes

The condition develops from prolonged or misuse of sedative, hypnotic, or anxiolytic substances, such as benzodiazepines or barbiturates. Dependence may arise from therapeutic use that progresses to misuse, while the psychotic disorder is triggered by the substance's effects on the central nervous system, often due to high doses or abrupt discontinuation.

Risk Factors

• A history of substance dependence or misuse.
• Co-occurring mental health disorders (e.g., anxiety, depression).
• Chronic stress or trauma.
• Environments where these substances are easily accessible.
• Genetic predispositions to addiction or psychosis.

Symptoms

• Compulsive need to use the substance, increased tolerance, and withdrawal symptoms when not using.
• Psychotic symptoms (e.g., delusions, hallucinations, paranoia) directly linked to substance use.
• Continued use despite physical or psychological harm, including the psychotic disorder.
• Impaired judgment or behavior due to both dependence and psychosis.

Diagnosis

Diagnosis requires a clinical evaluation, including patient history, symptom assessment, and ruling out other causes of psychosis (e.g., primary mental health conditions). Standardized criteria for substance dependence and substance-induced psychotic disorder are used, with confirmation that symptoms are not better explained by another disorder.

Treatment Options

Treatment typically involves a combination of behavioral therapies (e.g., cognitive-behavioral therapy), counseling, and support groups. Medication-assisted treatment may address withdrawal or underlying anxiety, while antipsychotics may be used cautiously for psychotic symptoms. Long-term management focuses on relapse prevention and addressing co-occurring conditions.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence and psychosis, as well as adherence to treatment. With proper management, symptoms may improve, but relapse risk remains. Regular follow-up is essential to monitor for recurrence of dependence or psychotic episodes, adjust treatment, and support recovery.

Complications

• Worsening of psychotic symptoms or development of chronic psychosis.
• Increased risk of overdose or self-harm.
• Social or occupational impairment due to dependence or psychosis.
• Co-occurring health issues (e.g., liver damage, respiratory depression) from substance use.

Lifestyle & Prevention

• Avoid non-prescribed use of sedative, hypnotic, or anxiolytic drugs.
• Follow prescribed dosages and durations strictly.
• Seek help for underlying mental health concerns to reduce self-medication.
• Build a support network (e.g., family, support groups) to aid recovery.
• Educate yourself about the risks of these substances, especially with prolonged use.

When to Seek Professional Help

Seek immediate care if you or someone else experiences severe psychotic symptoms (e.g., hallucinations, delusions), thoughts of self-harm, or uncontrolled substance use. Also, consult a healthcare provider for persistent withdrawal symptoms, cravings, or difficulty reducing use.

Tips for Medical Coders

Document the presence of both sedative, hypnotic, or anxiolytic dependence and the substance-induced psychotic disorder clearly. Ensure the psychotic symptoms are directly attributed to the substance use (not a primary psychotic disorder) and that both components of the diagnosis are supported by clinical findings. Code F13.25 is specific to dependence with a substance-induced psychotic disorder; avoid using it if the psychosis is unrelated to the substance.